Eterna Therapeutics Inc (ERNA) — Strategic Asset Allocation Index
Eterna Therapeutics Inc (ERNA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $2.23 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Eterna Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Eterna Therapeutics Inc Strategic Asset Allocation Index (2018–2023)
This chart shows how Eterna Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2018 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $2.23 Million USD. For live market cap and overall valuation, see ERNA market cap.
Annual Strategic Asset Allocation Index for Eterna Therapeutics Inc (2018–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Eterna Therapeutics Inc from 2018 to 2023, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Eterna Therapeutics Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $2.23 Million | ▼ -10.9 pp |
| 2022 | 10.9% | $1.32 Million | $1.27 Million | $59.00K | $12.11 Million | ▼ -5.7 pp |
| 2021 | 16.6% | $4.24 Million | $3.24 Million | $1.00 Million | $25.50 Million | ▼ -18.5 pp |
| 2020 | 35.1% | $2.69 Million | $2.69 Million | $0.00 | $7.66 Million | ▲ +22.2 pp |
| 2019 | 12.8% | $653.76K | $653.76K | $- | $5.09 Million | ▲ +11.9 pp |
| 2018 | 1.0% | $68.10K | $68.10K | $- | $6.92 Million | — |